Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 CAD | 0.00% | -5.88% | +11.63% |
Apr. 08 | Premier Health of America Inc. Announces Chief Technology Officer Changes | CI |
Feb. 26 | Premier Health of America Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company shows low valuation levels, with an enterprise value at 0.41 times its sales.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.63% | 19.47M | - | ||
-19.95% | 214B | B | ||
-9.06% | 66.27B | B- | ||
-3.37% | 56.38B | B | ||
-10.49% | 46.62B | A- | ||
+8.30% | 43.93B | C | ||
-6.51% | 34.19B | B | ||
-7.95% | 29.14B | B | ||
+85.24% | 24.32B | - | ||
+3.45% | 21.64B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- PHA Stock
- Ratings Premier Health of America Inc.